AMD affects one million Canadians, yet it is still poorly understood and causes much anxiety to those diagnosed with it: Will I go blind? Will I be able to lead a normal life? Can I be cured? This boo
AMD affects one million Canadians, yet it is still poorly understood and causes much anxiety to those diagnosed with it: Will I go blind? Will I be able to lead a normal life? Can I be cured?
This book addresses these and many other questions to help in understanding the impact of AMD in everyday life. In addition, the latest advances in AMD research are explained, as major therapeutic breakthroughs that have considerably improved the quality of life of people with AMD have been made in recent years and new treatments under development hold even more promise for the future.
Dr. Jean-Daniel Arbour is an ophthalmologist at Notre-Dame Hospital in Quebec.
Dr. Francine Behar-Cohen is an ophthalmologist based in Paris, France.
Dr. Pierre Labelle is an ophthalmologist at Maisonneuve-Rosemont Hospital in Quebec.
Dr. Florian Sennlaub is the Director of Research at INSERM in France.
Dr. Alan F. Creuss is a Professor and District Chief of the Department of Ophthalmology and Visual Science at Dalhousie University.
